FDA Issues Warning Letter and Import Alert on AkzoNobel’s API Plant in Mexico

The U.S. Food and Drug Administration (FDA) issued a warning letter last month to Akzo Nobel Chemicals’ (Los Reyes La Paz, Mexico) manufacturing plant at Los Reyes La Paz, for deviating from current good manufacturing practice (cGMP). An FDA inspection in June 2011 at the AkzoNobel active pharmaceutical ingredient (API) manufacturing facility at Los Reyes La Paz identified significant deviations from cGMP for the manufacture of APIs, FDA says. AkzoNobel responded on July 11, 2011 and the FDA says it has reviewed the response, and that the corrective actions...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers